Dexcom Inc

NASDAQ:DXCM  
447.16
-8.62 (-1.89%)
4:00:06 PM EDT: $446.29 -0.87 (-0.20%)
Other Pre-Announcement

Dexcom Reports Preliminary, Unaudited Q4 Revenue

Published: 01/10/2022 13:01 GMT
Dexcom Inc (DXCM) - Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter 2021 and Summary Data From the Dexcom G7 U.S. Pivotal Trial.
Expects Preliminary, Unaudited Revenue for Q4 Ended December 31, 2021 to Be About $698 Million.
For 2022, Anticipates Total Revenue of About $2.82 Billion to $2.94 Billion.
For Fiscal 2021, Total Preliminary, Unaudited Revenue is Expected to Be About $2.448 Billion.
Q4 Revenue View $696.5 Million -- Refinitiv Ibes Data (analyst estimates).
FY2022 Revenue View $2.99 Billion -- Refinitiv Ibes Data (analyst estimates).